Financials in USD. Standardized financial statements.
A compact view of how Sinopharm Group Co. Ltd. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $560.33B | $584.51B | $596.57B | $552.15B | $521.05B | $456.41B | $425.27B | $344.53B | $277.03B | $258.12B |
| Revenue Growth? | -4.1% | -2.0% | +8.0% | +6.0% | +14.2% | +7.3% | +23.4% | +24.4% | +7.3% | 0.0% |
| Cost of Revenue? | $520.17B | $540.25B | $548.06B | $504.71B | $477.00B | $416.09B | $387.74B | $313.30B | $254.64B | $237.72B |
| Gross Profit? | $40.15B | $44.26B | $48.51B | $47.43B | $44.05B | $40.32B | $37.53B | $31.23B | $22.39B | $20.40B |
| Gross Margin? | +7.2% | +7.6% | +8.1% | +8.6% | +8.5% | +8.8% | +8.8% | +9.1% | +8.1% | +7.9% |
| Operating Expenses? | $23.92B | $28.07B | $28.30B | $26.83B | $24.34B | $22.56B | $19.03B | $15.47B | $11.17B | $10.46B |
| Operating Income? | $16.24B | $16.19B | $20.21B | $20.60B | $19.71B | $17.76B | $16.14B | $15.40B | $11.91B | $10.21B |
| EBITDA? | $20.41B | $20.17B | $26.90B | $26.25B | $24.68B | $22.62B | $20.32B | $16.67B | $13.43B | $12.04B |
| Income Before Tax | $14.42B | $14.00B | $19.51B | $18.56B | $17.00B | $15.60B | $13.76B | $12.21B | $10.17B | $8.92B |
| Income Tax Expense | $3.86B | $3.58B | $4.50B | $4.22B | $3.94B | $3.50B | $3.14B | $2.80B | $2.30B | $2.03B |
| Net Income? | $6.97B | $7.05B | $9.05B | $8.53B | $7.76B | $7.19B | $10.62B | $9.40B | $7.87B | $4.65B |
| EPS? | $2.24 | $2.26 | $2.90 | $2.73 | $2.49 | $2.31 | $3.58 | $3.17 | $2.65 | $1.68 |
| Diluted EPS? | $2.24 | $2.26 | $2.90 | $2.73 | $2.49 | $2.31 | $3.57 | $3.16 | $2.65 | $1.68 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality